Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site
出版年份 2022 全文链接
标题
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 65, Issue 3, Pages 2388-2408
出版商
American Chemical Society (ACS)
发表日期
2022-01-05
DOI
10.1021/acs.jmedchem.1c01851
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development
- (2021) Pan Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of RSV-Induced BRD4 Protein Interactions Using Native Immunoprecipitation and Parallel Accumulation—Serial Fragmentation (PASEF) Mass Spectrometry
- (2021) Morgan Mann et al. Viruses-Basel
- Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases
- (2021) Yi Li et al. INFLAMMATORY BOWEL DISEASES
- Bromodomain Containing Protein 4 (BRD4) Regulates Expression of its Interacting Coactivators in the Innate Response to Respiratory Syncytial Virus
- (2021) Xiaofang Xu et al. Frontiers in Molecular Biosciences
- Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
- (2020) Emily J. Faivre et al. NATURE
- Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites
- (2020) Michael D. Olp et al. ACS Chemical Biology
- Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation
- (2020) Zhiqing Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580
- (2020) Edrous Alamer et al. JOURNAL OF VIROLOGY
- Opposing Functions of BRD4 Isoforms in Breast Cancer
- (2020) Shwu-Yuan Wu et al. MOLECULAR CELL
- Selective targeting of BD1 and BD2 of the BET proteins in cancer and immuno-inflammation
- (2020) Omer Gilan et al. SCIENCE
- Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties
- (2020) Eric A. Wold et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
- (2020) Zijun Zhou et al. Frontiers in Pharmacology
- Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant Behavior
- (2020) Pingyuan Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- GPCR Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications
- (2019) Eric A. Wold et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV
- (2019) Qingli Niu et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacoproteomics reveal novel protective activity of bromodomain containing 4 inhibitors on vascular homeostasis in TLR3-mediated airway remodeling
- (2019) Yingxin Zhao et al. Journal of Proteomics
- Targeting epigenetic machinery: Emerging novel allosteric inhibitors
- (2019) Fei Ye et al. PHARMACOLOGY & THERAPEUTICS
- Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling
- (2019) Allan R. Brasier et al. DRUG DISCOVERY TODAY
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
- (2018) Chaoyang Sun et al. CANCER CELL
- Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation
- (2018) Zhiqing Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor
- (2018) Christopher T. Wild et al. JOURNAL OF MEDICINAL CHEMISTRY
- Central Role of the NF-κB Pathway in the Scgb1a1 -Expressing Epithelium in Mediating Respiratory Syncytial Virus-Induced Airway Inflammation
- (2018) Bing Tian et al. JOURNAL OF VIROLOGY
- Plasticity in binding confers selectivity in ligand-induced protein degradation
- (2018) Radosław P. Nowak et al. Nature Chemical Biology
- Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
- (2018) Constantine S. Tam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation
- (2018) Bing Tian et al. Cell Reports
- Efficacy of Novel Highly Specific Bromodomain-Containing Protein 4 Inhibitors in Innate Inflammation-Driven Airway Remodeling
- (2018) Bing Tian et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Abstract 5789: Discovery of clinical candidate BMS-986158, an oral BET inhibitor, for the treatment of cancer
- (2018) Ashvinikumar V. Gavai et al. CANCER RESEARCH
- Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
- (2018) Eric A. Wold et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling
- (2018) Bing Tian et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Drug Discovery Targeting Bromodomain-Containing Protein 4
- (2017) Zhiqing Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
- (2017) Keith F. McDaniel et al. JOURNAL OF MEDICINAL CHEMISTRY
- BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection
- (2017) Bing Tian et al. JOURNAL OF VIROLOGY
- Brd4 modulates the innate immune response through Mnk2–eIF4E pathway-dependent translational control of IκBα
- (2017) Yan Bao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
- (2017) Qiming Duan et al. Science Translational Medicine
- Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition
- (2017) Jun Yang et al. Nature Microbiology
- Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins
- (2016) Brigitt Raux et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
- (2016) Brian K. Albrecht et al. JOURNAL OF MEDICINAL CHEMISTRY
- BRD4 Phosphorylation Regulates HPV E2-Mediated Viral Transcription, Origin Replication, and Cellular MMP-9 Expression
- (2016) Shwu-Yuan Wu et al. Cell Reports
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- Discovery of Chemical Inhibitors of Human Bromodomains
- (2015) Guangtao Zhang et al. CHEMICAL REVIEWS
- Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity
- (2015) G. C. Sartor et al. JOURNAL OF NEUROSCIENCE
- Direct Activation of Bax Protein for Cancer Therapy
- (2015) Zhiqing Liu et al. MEDICINAL RESEARCH REVIEWS
- BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice
- (2015) Erica Korb et al. NATURE NEUROSCIENCE
- Chronic obstructive pulmonary disease
- (2015) Peter J. Barnes et al. Nature Reviews Disease Primers
- Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
- (2014) Stuart W. J. Ember et al. ACS Chemical Biology
- Affinity Map of Bromodomain Protein 4 (BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1
- (2014) Marie Jung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
- (2014) P. Jeffrey Conn et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- 4-Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading
- (2013) Xavier Lucas et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Novel Nitrogen-Enriched Oridonin Analogues with Thiazole-Fused A-Ring: Protecting Group-Free Synthesis, Enhanced Anticancer Profile, and Improved Aqueous Solubility
- (2013) Chunyong Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
- (2013) Shwu-Yuan Wu et al. MOLECULAR CELL
- Emerging paradigms in GPCR allostery: implications for drug discovery
- (2013) Denise Wootten et al. NATURE REVIEWS DRUG DISCOVERY
- RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
- (2013) S. Picaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents
- (2013) Haijun Chen et al. ACS Medicinal Chemistry Letters
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- Down-regulation of NF-κB Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition
- (2012) Guangtao Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bacterial Reduction as Means for Colonic Drug Delivery: Can Other Chemical Groups Provide an Alternative to the Azo Bond?
- (2012) Sigal Saphier et al. JOURNAL OF MEDICINAL CHEMISTRY
- The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
- (2012) Zichong Li et al. NUCLEIC ACIDS RESEARCH
- Reactivation of Latent HIV-1 by Inhibition of BRD4
- (2012) Jian Zhu et al. Cell Reports
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM
- (2011) T. Geoff G. Battye et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- What makes a good drug target?
- (2011) Isabella Gashaw et al. DRUG DISCOVERY TODAY
- 7-Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents
- (2011) Evgeny Kiselev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
- (2008) P. Jeffrey Conn et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now